相关实验视频
Updated: Jun 12, 2025

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
通过JAK2/STAT3通路,CXCR4调节了通过TOX编程的CD8+ T细胞的耗尽表型
Canhui Cao1, Miaochun Xu2, Ye Wei1
1Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430199, China; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
CXCR4抗剂可以改善癌症免疫疗法. 这项研究揭示了CXCR4驱动T细胞疲劳,并阻止它恢复免疫功能,支持组合疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子医学是分子医学.
背景情况:
- 临床试验表明,CXCR4抗剂可以增强癌症免疫疗法.
- 对于CXCR4在免疫细胞表型中的作用的确切机制尚不清楚.
研究的目的:
- 阐明CXCR4在CD8+T细胞耗尽中的作用.
- 研究T细胞中CXCR4调节的机械路径.
- 为CXCR4抗剂组合治疗提供理由.
主要方法:
- 单细胞转录组分析 (scRNA-seq).
- 在体内实验中阻断CXCR4.
- 单细胞RNA/TCR/ATAC-seq. 的一个细胞.
- 临床样本分析.
主要成果:
- CXCR4是T细胞中的标记基因,在耗尽的CD8+T (Tex) 细胞中表达高.
- 在体内阻断CXCR4减弱了Tex表型.
- 通过CXCR4阻断,可以调节JAK2-STAT3通路.
- 缺乏Cxcr4的CD8+T细胞显示了表观遗传减轻疲劳.
- 增加的CXCR4+CD8+T细胞与患者的非完全病理反应相关.
结论:
- CXCR4调节CD8+Tex细胞的表型.
- 通过JAK2-STAT3通路,CXCR4抗剂可以逆转T细胞耗尽.
- 这些发现支持将CXCR4抗剂与免疫治疗结合起来,以提高疗效.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The JAK-STAT Signaling Pathway
The Extrinsic Apoptotic Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Anaphase Promoting Complex
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

